Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial. (2022)

First Author: Johansen ND
Attributed to:  RECOVERY/Phase 2 Therapeutic Trials Reconfiguration funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s40814-022-01044-w

PubMed Identifier: 35449028

Publication URI: http://europepmc.org/abstract/MED/35449028

Type: Journal Article/Review

Volume: 8

Parent Publication: Pilot and feasibility studies

Issue: 1

ISSN: 2055-5784